1. Home
  2. ENTX vs WW Comparison

ENTX vs WW Comparison

Compare ENTX & WW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
    SELLHOLDBUYas of 17 hours ago
  • WW
    SELLHOLDBUYas of 17 hours ago
  • Stock Information
  • Founded
  • ENTX 2010
  • WW 1961
  • Country
  • ENTX Israel
  • WW United States
  • Employees
  • ENTX N/A
  • WW N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • WW Other Consumer Services
  • Sector
  • ENTX Health Care
  • WW Consumer Discretionary
  • Exchange
  • ENTX Nasdaq
  • WW Nasdaq
  • Market Cap
  • ENTX 69.6M
  • WW 75.9M
  • IPO Year
  • ENTX 2018
  • WW 2001
  • Fundamental
  • Price
  • ENTX $1.70
  • WW $0.53
  • Analyst Decision
  • ENTX Strong Buy
  • WW Buy
  • Analyst Count
  • ENTX 1
  • WW 4
  • Target Price
  • ENTX $10.00
  • WW $3.44
  • AVG Volume (30 Days)
  • ENTX 52.4K
  • WW 2.0M
  • Earning Date
  • ENTX 03-28-2025
  • WW 05-01-2025
  • Dividend Yield
  • ENTX N/A
  • WW N/A
  • EPS Growth
  • ENTX N/A
  • WW N/A
  • EPS
  • ENTX N/A
  • WW N/A
  • Revenue
  • ENTX $181,000.00
  • WW $785,921,000.00
  • Revenue This Year
  • ENTX N/A
  • WW N/A
  • Revenue Next Year
  • ENTX N/A
  • WW N/A
  • P/E Ratio
  • ENTX N/A
  • WW N/A
  • Revenue Growth
  • ENTX N/A
  • WW N/A
  • 52 Week Low
  • ENTX $1.41
  • WW $0.38
  • 52 Week High
  • ENTX $3.35
  • WW $2.35
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 33.66
  • WW 42.85
  • Support Level
  • ENTX $1.85
  • WW $0.48
  • Resistance Level
  • ENTX $2.02
  • WW $0.63
  • Average True Range (ATR)
  • ENTX 0.10
  • WW 0.06
  • MACD
  • ENTX -0.01
  • WW 0.01
  • Stochastic Oscillator
  • ENTX 11.57
  • WW 26.91

Stock Price Comparison Chart: ENTX vs WW

ENTX
WW
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025051015202530354045ENTX VS WW

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About WW WW International Inc.

WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use